| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3884833
[patent_doc_number] => 05714334
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-03
[patent_title] => 'Gene and method for production of an IgA binding protein'
[patent_app_type] => 1
[patent_app_number] => 8/782009
[patent_app_country] => US
[patent_app_date] => 1997-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7472
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/714/05714334.pdf
[firstpage_image] =>[orig_patent_app_number] => 782009
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/782009 | Gene and method for production of an IgA binding protein | Jan 6, 1997 | Issued |
Array
(
[id] => 3933543
[patent_doc_number] => 05929032
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Method for treating Schwann and colon cells in vitro'
[patent_app_type] => 1
[patent_app_number] => 8/761038
[patent_app_country] => US
[patent_app_date] => 1996-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 6132
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/929/05929032.pdf
[firstpage_image] =>[orig_patent_app_number] => 761038
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/761038 | Method for treating Schwann and colon cells in vitro | Dec 4, 1996 | Issued |
Array
(
[id] => 3770062
[patent_doc_number] => 05849705
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Method for the treatment of Schwann cells in vivo'
[patent_app_type] => 1
[patent_app_number] => 8/761762
[patent_app_country] => US
[patent_app_date] => 1996-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 5847
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849705.pdf
[firstpage_image] =>[orig_patent_app_number] => 761762
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/761762 | Method for the treatment of Schwann cells in vivo | Dec 4, 1996 | Issued |
Array
(
[id] => 3785349
[patent_doc_number] => 05736400
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Method for modifying, diagnosing and screening for IGF-I sensitive cell barriers'
[patent_app_type] => 1
[patent_app_number] => 8/759264
[patent_app_country] => US
[patent_app_date] => 1996-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 10832
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736400.pdf
[firstpage_image] =>[orig_patent_app_number] => 759264
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/759264 | Method for modifying, diagnosing and screening for IGF-I sensitive cell barriers | Dec 1, 1996 | Issued |
| 08/749709 | PRODUCTION OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR AND DNA ENCODING SAME | Nov 14, 1996 | Abandoned |
| 08/749710 | PRODUCTION OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR AND DNA ENCODING SAME | Nov 14, 1996 | Abandoned |
Array
(
[id] => 4033320
[patent_doc_number] => 05856138
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Human parathyroid hormone muteins and production thereof'
[patent_app_type] => 1
[patent_app_number] => 8/733446
[patent_app_country] => US
[patent_app_date] => 1996-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 33
[patent_no_of_words] => 19723
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856138.pdf
[firstpage_image] =>[orig_patent_app_number] => 733446
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/733446 | Human parathyroid hormone muteins and production thereof | Oct 17, 1996 | Issued |
| 08/694809 | PRODUCTION OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR AND DNA ENCODING SAME | Aug 8, 1996 | Abandoned |
Array
(
[id] => 3848266
[patent_doc_number] => 05719127
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-17
[patent_title] => 'Modified complement system regulators'
[patent_app_type] => 1
[patent_app_number] => 8/688675
[patent_app_country] => US
[patent_app_date] => 1996-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 10150
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 623
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/719/05719127.pdf
[firstpage_image] =>[orig_patent_app_number] => 688675
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/688675 | Modified complement system regulators | Jul 29, 1996 | Issued |
Array
(
[id] => 3738600
[patent_doc_number] => 05753502
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Neuron-specific ICAM-4 promoter'
[patent_app_type] => 1
[patent_app_number] => 8/656984
[patent_app_country] => US
[patent_app_date] => 1996-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18457
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753502.pdf
[firstpage_image] =>[orig_patent_app_number] => 656984
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/656984 | Neuron-specific ICAM-4 promoter | Jun 5, 1996 | Issued |
Array
(
[id] => 3862083
[patent_doc_number] => 05837242
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Multivalent and multispecific binding proteins, their manufacture and use'
[patent_app_type] => 1
[patent_app_number] => 8/448418
[patent_app_country] => US
[patent_app_date] => 1996-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 52
[patent_no_of_words] => 49061
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837242.pdf
[firstpage_image] =>[orig_patent_app_number] => 448418
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/448418 | Multivalent and multispecific binding proteins, their manufacture and use | May 13, 1996 | Issued |
| 08/605185 | GLYCOPHORIN BINDING PROTEIN (GBP130) FUSION COMPOSITIONS | Feb 28, 1996 | Abandoned |
Array
(
[id] => 3693681
[patent_doc_number] => 05661005
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => '.beta.3 integrin subunit specific polypeptides, cDNAS which encode these polypeptides and methods of producing these polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/597583
[patent_app_country] => US
[patent_app_date] => 1996-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3765
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/661/05661005.pdf
[firstpage_image] =>[orig_patent_app_number] => 597583
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/597583 | .beta.3 integrin subunit specific polypeptides, cDNAS which encode these polypeptides and methods of producing these polypeptides | Feb 1, 1996 | Issued |
Array
(
[id] => 4044887
[patent_doc_number] => 05869270
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-09
[patent_title] => 'Single chain MHC complexes and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/596387
[patent_app_country] => US
[patent_app_date] => 1996-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 82
[patent_no_of_words] => 46590
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/869/05869270.pdf
[firstpage_image] =>[orig_patent_app_number] => 596387
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/596387 | Single chain MHC complexes and uses thereof | Jan 30, 1996 | Issued |
| 08/554374 | FLK-1 BINDING PROTEIN | Nov 7, 1995 | Abandoned |
Array
(
[id] => 3850516
[patent_doc_number] => 05767077
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Human Fc-.gamma. receptor III'
[patent_app_type] => 1
[patent_app_number] => 8/481939
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6128
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767077.pdf
[firstpage_image] =>[orig_patent_app_number] => 481939
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/481939 | Human Fc-.gamma. receptor III | Jun 6, 1995 | Issued |
Array
(
[id] => 3888508
[patent_doc_number] => 05723583
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Antibody containing sialyl lewis X determinants'
[patent_app_type] => 1
[patent_app_number] => 8/480036
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 22
[patent_no_of_words] => 7981
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723583.pdf
[firstpage_image] =>[orig_patent_app_number] => 480036
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/480036 | Antibody containing sialyl lewis X determinants | Jun 6, 1995 | Issued |
Array
(
[id] => 3818380
[patent_doc_number] => 05770686
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-23
[patent_title] => 'ICAM-related protein fragments'
[patent_app_type] => 1
[patent_app_number] => 8/474368
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 38
[patent_no_of_words] => 35716
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/770/05770686.pdf
[firstpage_image] =>[orig_patent_app_number] => 474368
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/474368 | ICAM-related protein fragments | Jun 6, 1995 | Issued |
Array
(
[id] => 3646033
[patent_doc_number] => 05629162
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-13
[patent_title] => 'Method of identifying agents which modulate ICAM-3 binding to LFA-1'
[patent_app_type] => 1
[patent_app_number] => 8/473981
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 49
[patent_no_of_words] => 22419
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/629/05629162.pdf
[firstpage_image] =>[orig_patent_app_number] => 473981
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473981 | Method of identifying agents which modulate ICAM-3 binding to LFA-1 | Jun 6, 1995 | Issued |
Array
(
[id] => 3743757
[patent_doc_number] => 05716789
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-10
[patent_title] => 'Method to determine ligands, agonist and antagonist of C140 receptor'
[patent_app_type] => 1
[patent_app_number] => 8/476000
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 15377
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/716/05716789.pdf
[firstpage_image] =>[orig_patent_app_number] => 476000
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/476000 | Method to determine ligands, agonist and antagonist of C140 receptor | Jun 6, 1995 | Issued |